Abstract
This cohort study investigates the humoral response to 2 SARS-CoV-2 messenger RNA vaccines in patients with multiple sclerosis treated with fingolimod and ocrelizumab.
All Keywords
【초록키워드】 SARS-CoV-2, Vaccine, multiple sclerosis, cohort study, Patient, humoral, Messenger RNA, treated, 【제목키워드】 SARS-CoV-2, response, infusion, Multiple, sclerosis,
【초록키워드】 SARS-CoV-2, Vaccine, multiple sclerosis, cohort study, Patient, humoral, Messenger RNA, treated, 【제목키워드】 SARS-CoV-2, response, infusion, Multiple, sclerosis,